Jaka jest cena za Vycor Medical, Inc. (VYCO)

Cena za Vycor Medical, Inc. (VYCO) wynosi $0.069

Jaka jest kapitalizacja rynkowa dla Vycor Medical, Inc. (VYCO)

Kapitalizacja rynkowa dla Vycor Medical, Inc. (VYCO) wynosi $2.30M

Przychody Vycor Medical, Inc. (VYCO)

Vycor Medical, Inc. (VMI) is dedicated to the creation, development, and commercialization of neurological medical devices and therapeutic solutions, operating in both the United States and European markets. The company's operations are divided into two primary business units. The Vycor Medical division specializes in neurosurgical instrumentation, providing devices such as the ViewSite Brain Access System—a critical retraction and access tool used in brain and spine surgeries. Conversely, the NovaVision segment delivers advanced, non-invasive, computer-based rehabilitation programs aimed at helping individuals with vision impairments resulting from strokes or other brain injuries. VMI has also established a strategic license and transition agreement with HelferApp GmbH, authorizing HelferApp to distribute NovaVision's products and therapies to patients and healthcare providers in Austria and Switzerland. The company's main clientele consists of hospitals and various medical professionals. Established in 2005, Vycor Medical, Inc. is headquartered in Boca Raton, Florida, and functions as a subsidiary of Fountainhead Capital Management Limited.

Rok	Przychody	Zmień
Za mało danych dla podanych dat.

Rok

Przychody

Zmień

Za mało danych dla podanych dat.

Firma	Przychody	Różnica w przychodach	Kraj
Abbott Laboratories ABT.US	$46.59B	-	US
Stryker Corporation SYK.US	$25.84B	-	US
Medtronic plc MDT.US	$35.48B	-	IE
Boston Scientific Corporation BSX.US	$21.00B	-	US
Edwards Lifesciences Corporation EW.US	$6.51B	-	US

Firma

Przychody

Różnica w przychodach

Kraj